Unum Therapeutics Inc at Morgan Stanley Healthcare Conference Transcript
Let me get started. So my name is Vikram Purohit. I'm one of the biotech analysts here at Morgan Stanley. And before we get into it with Unum Therapeutics, just I need to let everyone know that for all important disclosures, you can see the Morgan Stanley research disclosures website at www.morganstanley.com/researchdisclosures. And with that, happy to have with me on the stage Unum Therapeutics' CEO, Chuck Wilson. Welcome.
Thank you.
So before we get into program-specific Q&A, I think it'd be good to take a couple of minutes and go to some opening remarks about where the company is now, what some of the corporate highlights are, and a quick overview of the ACTR platform and then we can go into some specifics.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
